DSS Inc
DSS0.918USD
-0.042-4.37%
Close 12/31, 16:00（ET）Quotes delayed by 15 min
8.35MMarket Cap
LossP/E TTM
More Details of DSS Inc Company
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.
DSS Inc Info
Ticker SymbolDSS
Company nameDSS Inc
IPO dateOct 27, 1993
CEOGrady (Jason)
Number of employees100
Security typeOrdinary Share
Fiscal year-endOct 27
Address275 Wiregrass Pkwy
CityWEST HENRIETTA
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code14586
Phone15852321500
Websitehttps://www.dssworld.com/
Ticker SymbolDSS
IPO dateOct 27, 1993
CEOGrady (Jason)
Company Executives of DSS Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Packaging Printing and Fabrication
4.15M
78.52%
Commercial and Security Printing
122.00K
2.31%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Packaging Printing and Fabrication
4.15M
78.52%
Commercial and Security Printing
122.00K
2.31%
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
The Vanguard Group, Inc.
0.71%
Renaissance Technologies LLC
0.35%
Other
32.76%
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
The Vanguard Group, Inc.
0.71%
Renaissance Technologies LLC
0.35%
Other
32.76%
Shareholder Types
Shareholders
Proportion
Corporation
43.57%
Individual Investor
22.62%
Investment Advisor
0.95%
Hedge Fund
0.37%
Investment Advisor/Hedge Fund
0.25%
Research Firm
0.03%
Other
32.21%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
35
145.92K
1.60%
-49.38K
2025Q3
36
145.92K
2.15%
-17.92K
2025Q2
35
163.84K
2.17%
-884.00
2025Q1
35
164.73K
1.72%
+7.88K
2024Q4
38
121.90K
3.03%
-50.52K
2024Q3
42
172.42K
3.04%
-10.61K
2024Q2
46
183.03K
2.83%
+19.66K
2024Q1
49
163.37K
2.83%
-36.31K
2023Q4
48
186.92K
3.41%
+16.51K
2023Q3
52
170.94K
7.14%
-2.49K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Alset Ehome International Inc
3.65M
40.14%
-581.39K
-13.74%
Oct 06, 2025
Chan (Heng Fai Ambrose)
2.06M
22.62%
--
--
Oct 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Oct 06, 2025
The Vanguard Group, Inc.
64.83K
0.71%
+43.10K
+198.36%
Sep 30, 2025
Renaissance Technologies LLC
31.45K
0.35%
+4.00K
+14.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.84K
0.25%
+3.65K
+18.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Sep 30, 2025
Citi Investment Research (US)
2.94K
0.03%
+2.94K
--
Sep 30, 2025
Tower Research Capital LLC
2.54K
0.03%
-1.89K
-42.63%
Sep 30, 2025
Wells Fargo Advisors
157.00
0%
+155.00
+7750.00%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
Date
Type
Ratio
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
FAQs
Who are the top five shareholders of DSS Inc?
The top five shareholders of DSS Inc are:
Alset Ehome International Inc holds 3.65M shares, accounting for 40.14% of the total shares.
Chan (Heng Fai Ambrose) holds 2.06M shares, accounting for 22.62% of the total shares.
Global Biomedical Pte Ltd. holds 311.63K shares, accounting for 3.43% of the total shares.
The Vanguard Group, Inc. holds 64.83K shares, accounting for 0.71% of the total shares.
Renaissance Technologies LLC holds 31.45K shares, accounting for 0.35% of the total shares.
Alset Ehome International Inc holds 3.65M shares, accounting for 40.14% of the total shares.
Chan (Heng Fai Ambrose) holds 2.06M shares, accounting for 22.62% of the total shares.
Global Biomedical Pte Ltd. holds 311.63K shares, accounting for 3.43% of the total shares.
The Vanguard Group, Inc. holds 64.83K shares, accounting for 0.71% of the total shares.
Renaissance Technologies LLC holds 31.45K shares, accounting for 0.35% of the total shares.
What are the top three shareholder types of DSS Inc?
The top three shareholder types of DSS Inc are:
Alset Ehome International Inc
Chan (Heng Fai Ambrose)
Global Biomedical Pte Ltd.
Alset Ehome International Inc
Chan (Heng Fai Ambrose)
Global Biomedical Pte Ltd.
How many institutions hold shares of DSS Inc (DSS)?
As of 2025Q4, 35 institutions hold shares of DSS Inc, with a combined market value of approximately 145.92K, accounting for 1.60% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.54%.
What is the biggest source of revenue for DSS Inc?
In FY2025Q2, the Packaging Printing and Fabrication business generated the highest revenue for DSS Inc, amounting to 4.15M and accounting for 78.52% of total revenue.
